Findings showed a greater proportion of patients achieved sustained complete remission with obinutuzumab vs mycophenolate mofetil at week 52. Topline data were announced from a phase 3 study ...

Whether or not you study inside the toilet bowl, this anomaly can stand out. A doctor speaks to the common causes for oily ...

A group led by the Department of Cell Biology at the Kidney Research Center, Niigata University revealed that elevated activity of cdc42 is a critical initiation event leading to proteinuria, and ...

A new study from Nepal published in the BMC Nephrology found no obvious clinical variables to predict how quickly children ...

I am currently caring for a 74-year-old man with a 2-month history of progressive nephrotic syndrome and cholestatic jaundice. What are the most likely diagnoses to consider? This is a challenging ...

For children with nephrotic syndrome, there was no difference in time to relapse between two commonly used non-steroid immunosuppressive medications, according to an observational study that emulated ...

A groundbreaking study, presented today at the 61st ERA Congress, has uncovered a significant breakthrough in the diagnosis and monitoring of kidney diseases associated with nephrotic syndrome. Using ...

Children with frequently relapsing or steroid-dependent nephrotic syndrome had a significantly longer relapse-free survival period with tacrolimus than with mycophenolate mofetil. Relapse-free ...

Please provide your email address to receive an email when new articles are posted on . The tacrolimus group had a 1.86-fold higher rate of relapse-free survival vs. those assigned mycophenolate ...

In a small study, proteinuria improved even in patients with nephrotic syndrome and lupus nephritis. Belimumab appears similarly effective and well tolerated in patients with lupus nephritis (LN) with ...